A study investigating the prognostic significance of EZH2 mutations in follicular lymphoma found that patients with mutated EZH2 had significantly shorter progression-free survival compared to those with wild-type EZH2 [13]. The gene discussed is EZH2; the disease is follicular lymphoma.